We are live on ! Find out more
CG

Carlyle Group Portfolio holdings

AUM $10.6B
1-Year Est. Return 11.25%
This Fund
S&P 500
This Quarter Est. Return
+0.68%
1 Year Est. Return
+11.25%
3 Year Est. Return
-0.47%
5 Year Est. Return
-4.92%
10 Year Est. Return
+7.54%
AUM
$2.31B
AUM Growth
-$502M
Cap. Flow
-$9.67M
Cap. Flow %
-0.42%
Top 10 Hldgs %
95.16%
Holding
27
New
1
Increased
1
Reduced
3
Closed
2

Top Buys

Rank Stock Value
1
SPWR icon
SunPower Inc
SPWR
+$10M
2
SLNO
Soleno Therapeutics
SLNO
+$6.61M

Top Sells

Rank Stock Value
1
VERA icon
Vera Therapeutics
VERA
+$16.8M
2
GTM
ZoomInfo Technologies
GTM
+$5.83M
3
PRTK
Paratek Pharmaceuticals, Inc.
PRTK
+$2.3M
4
GETY icon
Getty Images
GETY
+$1.28M
5
SYRE icon
Spyre Therapeutics
SYRE
+$108K

Sector Composition

Rank Sector Weight
1 Healthcare 49.41%
2 Technology 41.11%
3 Consumer Staples 4.78%
4 Communication Services 2.74%
5 Real Estate 1.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SYRE icon
26
Spyre Therapeutics
SYRE
$8.7B
– –
-9,620
Closed -$108K
PRTK
27
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
– –
-1,041,131
Closed -$2.3M
1
2

Similar funds

SGA
Sustainable Growth Advisers Stamford, Connecticut $10.6B AUM 2.6% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
BMSSC
B. Metzler seel. Sohn & Co Frankfurt, Germany $10.8B AUM 21.99% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
HTC
Haverford Trust Company Radnor, Pennsylvania $10.9B AUM 18.64% 1-Year Est. Return
CA
Clearstead Advisors Cleveland, Ohio $10.9B AUM 18.41% 1-Year Est. Return
OIA
OneDigital Investment Advisors Overland Park, Kansas $10.2B AUM 16.58% 1-Year Est. Return

Carlyle Group's Q3 2023 Portfolio in Review

As of Q3 2023, Carlyle Group held 27 positions worth $2.31B, down 18% from $2.81B the previous quarter. Its ten largest holdings account for 95% of the portfolio.

Carlyle Group's Q3 2023 filing shows 1 new, 1 increased, 3 reduced and 2 closed positions. Its largest new stake was SunPower Inc: 2,495,879 shares worth $5.14M. The largest sale was Vera Therapeutics, an estimated $16.8M.

By sector, the portfolio is most concentrated in Healthcare at 49% of assets, up from 45% a quarter earlier, followed by Technology and Consumer Staples.

  • Carlyle Group's largest Q3 2023 buy was SunPower Inc: 2,495,879 shares worth $5.14M.
  • Carlyle Group added most to Soleno Therapeutics in Q3 2023, an estimated $6.61M increase.
  • Carlyle Group's biggest Q3 2023 reduction was Vera Therapeutics, cutting an estimated $16.8M.
  • Carlyle Group fully exited Paratek Pharmaceuticals, Inc. in Q3 2023, selling an estimated $2.3M.
  • Carlyle Group's ten largest holdings make up 95% of its $2.31B portfolio in Q3 2023.
  • Carlyle Group opened 1 new position and closed 2 in Q3 2023.
  • Carlyle Group's portfolio value fell 18% quarter-over-quarter to $2.31B.

Based on Carlyle Group's 13F filing for Q3 2023, filed 3 Nov 2023.